Company

LimmaTech Biologics AG was founded in 2015 in Switzerland and is a privately owned clinical stage biotech company. We research innovative ways of bioengineering complex structures to develop novel pharmaceuticals. With the advent of new technologies and the long-standing experience of its staff, the company is at the forefront of in vivo carbohydrate engineering.

We are currently conducting a clinical trial in Kenya for a vaccine against Shigella infections in collaboration with GSK and the Wellcome Trust.

We use cookies to make this website work better for you and to track site visits anonymously. You can opt out if you like. ­Tell me more

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close